0000950159-24-000132.txt : 20240426 0000950159-24-000132.hdr.sgml : 20240426 20240426163026 ACCESSION NUMBER: 0000950159-24-000132 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240424 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240426 DATE AS OF CHANGE: 20240426 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cigna Group CENTRAL INDEX KEY: 0001739940 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 824991898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38769 FILM NUMBER: 24884357 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Cigna Corp DATE OF NAME CHANGE: 20181221 FORMER COMPANY: FORMER CONFORMED NAME: Halfmoon Parent, Inc. DATE OF NAME CHANGE: 20180508 8-K 1 cigna8k.htm THE CIGNA GROUP FORM 8-K Voting Results - The Cigna Group Form 8-K
false 0001739940 0001739940 2024-04-24 2024-04-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 8-K

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

 

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) April 24, 2024

 

The Cigna Group

 

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of

 

incorporation)

001-38769

(Commission File Number)

82-4991898

(IRS Employer

Identification No.)

 


900 Cottage Grove Road

Bloomfield, Connecticut 06002

 

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code:

 

(860) 226-6000

 

Not Applicable

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, Par Value $0.01 CI New York Stock Exchange, Inc.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

The Cigna Group (the “Company”) held its Annual Meeting of Shareholders on April 24, 2024 (the “Annual Meeting”). Of the 283,647,404 shares outstanding and entitled to vote, 256,548,480 shares, or 90.44%, were represented in person or by proxy at the Annual Meeting. The results for each of the proposals submitted to a vote of our shareholders at the Annual Meeting are set forth below. Each proposal is described in more detail in our 2024 Proxy Statement, filed with the Securities and Exchange Commission on March 15, 2024.

Proposal 1: Shareholders elected the twelve director nominees named in the 2024 Proxy Statement for one-year terms to expire at the next annual meeting of shareholders.

Nominees Votes For Votes Against Abstentions Broker
Non-Votes
David M. Cordani  222,758,788  12,902,745 1,147,429 19,739,518
William J. DeLaney  232,196,284 4,331,167 281,511 19,739,518
Eric J. Foss  228,009,859 8,508,086  291,017 19,739,518
Elder Granger, M.D., MG, USA, Retired 232,236,431   4,290,314  282,217 19,739,518
Neesha Hathi  236,082,349   430,584  296,029 19,739,518
George Kurian 232,308,341 4,188,371 312,250 19,739,518
Kathleen M. Mazzarella 227,364,644 9,180,359 263,959 19,739,518
Mark B. McClellan, M.D., Ph.D. 232,205,786 4,326,639 276,537 19,739,518
Philip O. Ozuah, M.D., Ph.D. 234,583,162 1,919,850 305,950 19,739,518
Kimberly A. Ross 233,807,317 2,736,909 264,736 19,739,518
Eric C. Wiseman 232,313,905 4,202,534 292,523 19,739,518
Donna F. Zarcone 223,367,678 13,175,903 265,381 19,739,518

 

In addition, shareholders voted on the following proposals and cast their votes as described below.

Proposal 2: Advisory approval of The Cigna Group’s executive compensation.

 

Votes For Votes Against Abstentions Broker Non-Votes
197,173,863 39,200,994 434,105 19,739,518

 

Proposal 3: Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group’s independent registered public accounting firm for 2024.

 

Votes For Votes Against Abstentions  
237,481,094 18,876,505 190,881  

 

 

   

 

 

Proposal 4: Shareholder Proposal – Improve the shareholder right to call a special shareholder meeting.

       
Votes For Votes Against Abstentions Broker Non-Votes
114,022,412 119,621,641 3,164,909 19,739,518
           

 

Proposal 5: Shareholder Proposal – Report to shareholders on risks created by the Company's diversity, equity, and inclusion efforts.

 

Votes For Votes Against Abstentions Broker Non-Votes
3,720,474 231,360,098 1,728,390 19,739,518

 

 

 

   

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  THE CIGNA GROUP
   
Date:  April 26, 2024 By: /s/ Nicole S. Jones       
    Nicole S. Jones
   

Executive Vice President, Chief Administrative Officer and General Counsel

 

  

 EX-101.SCH 2 ci-20240424.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 ci-20240424_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 4 ci-20240424_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover
Apr. 24, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Apr. 24, 2024
Entity File Number 001-38769
Entity Registrant Name The Cigna Group
Entity Central Index Key 0001739940
Entity Tax Identification Number 82-4991898
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 900 Cottage Grove Road
Entity Address, City or Town Bloomfield
Entity Address, State or Province CT
Entity Address, Postal Zip Code 06002
City Area Code 860
Local Phone Number 226-6000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, Par Value $0.01
Trading Symbol CI
Security Exchange Name NYSE
Entity Emerging Growth Company false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 1 22 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://thecignagroup.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ci-20240424.xsd ci-20240424_lab.xml ci-20240424_pre.xml cigna8k.htm http://xbrl.sec.gov/dei/2024 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "cigna8k.htm": { "nsprefix": "CI", "nsuri": "http://thecignagroup.com/20240424", "dts": { "schema": { "local": [ "ci-20240424.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "labelLink": { "local": [ "ci-20240424_lab.xml" ] }, "presentationLink": { "local": [ "ci-20240424_pre.xml" ] }, "inline": { "local": [ "cigna8k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 22 }, "report": { "R1": { "role": "http://thecignagroup.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-04-24", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "cigna8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-04-24", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "cigna8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://thecignagroup.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 14 0000950159-24-000132-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950159-24-000132-xbrl.zip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end XML 16 cigna8k_htm.xml IDEA: XBRL DOCUMENT 0001739940 2024-04-24 2024-04-24 iso4217:USD shares iso4217:USD shares false 0001739940 8-K 2024-04-24 The Cigna Group DE 001-38769 82-4991898 900 Cottage Grove Road Bloomfield CT 06002 860 226-6000 false false false false Common Stock, Par Value $0.01 CI NYSE false